Form 4: Health Catalyst Executive Linda Llewelyn Sells Shares Under 10b5-1 Plan
SEC Form 4 Filing
Linda Llewelyn, Chief People Officer of Health Catalyst, Inc., sold 2,005 shares of common stock at $6.11 per share on April 15, 2024, under a pre-arranged trading plan.
Summary
- Linda Llewelyn, the Chief People Officer of Health Catalyst, Inc., reported a transaction involving the sale of company stock.
- On April 15, 2024, Llewelyn sold 2,005 shares of common stock at a price of $6.11 per share.
- The sale was executed under a pre-arranged trading plan adopted on May 23, 2023, in accordance with Rule 10b5-1.
- Following the transaction, Llewelyn still beneficially owns 126,226 shares of Health Catalyst common stock.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing detailing a stock sale under a pre-arranged trading plan. It doesn't inherently convey positive or negative sentiment.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions. It provides transparency into the trading activities of company executives and their potential impact on the stock's price and investor sentiment.
Stakeholder Impact
- The stock sale may have a minor impact on shareholders, potentially causing a slight decrease in stock price due to increased supply.
Key Dates
| Date | Description |
|---|---|
| May 23, 2023 | Date the reporting person adopted the written trading plan in accordance with Rule 10b5-1 |
| April 15, 2024 | Date of the stock sale transaction |
| April 17, 2024 | Date of signature for the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.